Medical News

RSS

Study: Scientists advance toward development of urine test for detecting colon cancer

Scientists are reporting an advance toward development of a urine test for detecting colon cancer, the third most common cancer in the United States. Such a test could eventually compliment or even reduce the need for colonoscopy, the mainstay screening test used today. The study, which analyzes chemical differences in the urine of humans with and without colon cancer, is in ACS' Journal of Proteome Research, a monthly publication.

22 Apr 2010

Senate Democrats seek legislation to regulate insurer rate hikes

The New York Times: "Fearing that health insurance premiums may shoot up in the next few years, Senate Democrats laid a foundation on Tuesday for federal regulation of rates, four weeks after President Obama signed a law intended to rein in soaring health costs." Sen. Dianne Feinstein, D-Calif., introduced legislation that would allow the federal health secretary to block "any rate increase found to be unreasonable," an authority that would be shared with some state insurance officials.

22 Apr 2010

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

22 Apr 2010

Young Innovations' first-quarter sales increases 4.3% to $24.8M

Young Innovations, Inc. today announced record sales and earnings per share for the quarter ended March 31, 2010.

22 Apr 2010

Clinical Xpert suite of mobile clinical workflow solutions available to clinicians

Thomson Reuters announced today that it will support the iPhone platform for its Clinical Xpert suite of mobile clinical workflow solutions.

22 Apr 2010

Delcath Systems' trial meets primary endpoint of extended hPFS in patients with melanoma metastases

Delcath Systems, Inc., a development stage, oncology-focused, specialty pharmaceutical and medical device company, announced that its Phase III National Cancer Institute (NCI)-led multi-center clinical trial has successfully met the study's primary endpoint of extended hepatic progression-free survival (hPFS) in patients with melanoma metastases to the liver based on an independently corroborated intent-to-treat analysis.

22 Apr 2010

2008 Physical Activity Guidelines for Americans interpreted for practical use by health care professionals

The first formal U.S. government recommendations on physical activity, the Physical Activity Guidelines for Americans, were published in 2008. Now, those guidelines have been interpreted for practical use by health care professionals in the American Journal of Lifestyle Medicine, published by SAGE.

22 Apr 2010

Obama puts health care on 'back burner'

The Washington Post: President Barack Obama seems to have put health care on the back burner as he focuses on financial reform and nuclear proliferation.

22 Apr 2010

Affymetrix reports first-quarter total revenue of $80.2M

Affymetrix, Inc., today reported its operating results for the first quarter of 2010. Total revenue for the quarter was $80.2 million, as compared to total revenue of $78.6 million in the first quarter of 2009.

22 Apr 2010

LIJ Medical Center to acquire TrueBeam system for cancer treatment

In a promising development for cancer patients in the New York metropolitan area, the Long Island Jewish (LIJ) Medical Center Department of Radiation Medicine announced today that it will acquire an innovative new system called TrueBeam that offers a radically different approach to treating cancer with image-guided radiotherapy.

22 Apr 2010

Cook Medical enrolls first patient in Formula PTX Balloon Expandable Renal Stent trial

Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.

22 Apr 2010

People with vitiligo may have less risk of developing malignant melanoma: Research

People with the skin pigmentation disorder vitiligo may have less risk of developing life-threatening malignant melanoma, according to new research. The study also further confirms the suspicion that vitiligo is an autoimmune disease, which occur when the body's immune system reacts against its own tissues or organs.

22 Apr 2010

Legal case asks who to blame for medical device failure

The New York Times: A legal case now pending asks a question increasingly faced by the medical world -- "who should be held accountable when a company sells a flawed product that can injure or kill patients? Is it the company or the people who run it?"

22 Apr 2010

Medtronic acquires Invatec

Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.

22 Apr 2010

DynaVox prices initial public offering at $15.00 per share

DynaVox Inc., a leading provider of software, devices and content to assist people in overcoming their speech, language or learning disabilities, announced today that its initial public offering of 9,375,000 shares of its Class A common stock has been priced at $15.00 per share. The shares are expected to begin trading tomorrow, April 22, 2010, on the NASDAQ Global Select Market under the ticker symbol "DVOX."

22 Apr 2010

Access Pharmaceuticals to present MuGard clinical data at 2010 MASCC conference

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today that it will present data from the ongoing work involving its lead product, MuGard, and host an oral mucositis symposium at the MASCC conference being held in Vancouver, B.C. on June 24-26, 2010. MuGard is Access Pharma's FDA-approved product for the management of oral mucositis, a debilitating side effect of many anticancer treatments.

22 Apr 2010

Mammographic density is one of the strongest predictors of breast cancer risk: Researchers

Women who have a breast density of 75 percent or higher on a mammogram have a risk of breast cancer that is four to five times greater than that of women with little or no density, making mammographic breast density one of the strongest biomarkers of breast cancer risk.

22 Apr 2010

Health record push lacks FDA oversight, risks safety problems

The Huffington Post Investigative Fund: "As federal officials encourage the rapid expansion of electronic medical records to help doctors improve care and cut costs, they lack a reliable and systematic method for tracking the safety of these products, agency data and audits show. Instead, the Food and Drug Administration depends on a spotty warning system that can take a year to flag serious computer malfunctions and other software glitches.

22 Apr 2010

Berwick may face difficult confirmation in Senate

News outlets continue to report on Donald Berwick, who was nominated by President Barack Obama to be administrator of the Centers for Medicare and Medicaid Services.

22 Apr 2010

Positive results from initial clinical trial of ClariVein catheter

Results from the initial clinical trial of the ClariVein® catheter, used in a new minimally invasive treatment for varicose veins, have been announced. The device combines mechanical and chemical modalities to accomplish vein treatment in an in-office setting.

22 Apr 2010

Medical News

Study: Scientists advance toward development of urine test for detecting colon cancer

Senate Democrats seek legislation to regulate insurer rate hikes

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Young Innovations' first-quarter sales increases 4.3% to $24.8M

Clinical Xpert suite of mobile clinical workflow solutions available to clinicians

Delcath Systems' trial meets primary endpoint of extended hPFS in patients with melanoma metastases

2008 Physical Activity Guidelines for Americans interpreted for practical use by health care professionals

Obama puts health care on 'back burner'

Affymetrix reports first-quarter total revenue of $80.2M

LIJ Medical Center to acquire TrueBeam system for cancer treatment

Cook Medical enrolls first patient in Formula PTX Balloon Expandable Renal Stent trial

People with vitiligo may have less risk of developing malignant melanoma: Research

Legal case asks who to blame for medical device failure

Medtronic acquires Invatec

DynaVox prices initial public offering at $15.00 per share

Access Pharmaceuticals to present MuGard clinical data at 2010 MASCC conference

Mammographic density is one of the strongest predictors of breast cancer risk: Researchers

Health record push lacks FDA oversight, risks safety problems

Berwick may face difficult confirmation in Senate

Positive results from initial clinical trial of ClariVein catheter

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News